UB
TEVA icon

UMB Bank’s Teva Pharmaceuticals TEVA Stock Holding History

UMB Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
3,844
+118
+3% +$3.93K ﹤0.01% 922
2026
Q1 		$112K Hold
3,726
– – ﹤0.01% 927
2025
Q4 		$116K Buy
3,726
+261
+8% +$6.43K ﹤0.01% 881
2025
Q3 		$70K Buy
3,465
+194
+6% +$3.41K ﹤0.01% 1013
2025
Q2 		$54.8K Buy
3,271
+492
+18% +$7.94K ﹤0.01% 1087
2025
Q1 		$42.7K Buy
2,779
+50
+2% +$893 ﹤0.01% 1118
2024
Q4 		$60.1K Buy
2,729
+290
+12% +$5.28K ﹤0.01% 840
2024
Q3 		$44K Buy
2,439
+2,067
+556% +$36.2K ﹤0.01% 914
2024
Q2 		$6.04K Sell
372
-3
-0.8% -$46 ﹤0.01% 1377
2024
Q1 		$5.29K Hold
375
– – ﹤0.01% 1375
2023
Q4 		$3.92K Sell
375
-205
-35% -$1.91K ﹤0.01% 1436
2023
Q3 		$5.92K Buy
580
+375
+183% +$3.49K ﹤0.01% 1391
2023
Q2 		$1.54K Sell
205
-505
-71% -$4.09K ﹤0.01% 1538
2023
Q1 		$6.28K Buy
710
+505
+246% +$4.99K ﹤0.01% 1379
2022
Q4 		$2K Hold
205
– – ﹤0.01% 1573
2022
Q3 		$2K Hold
205
– – ﹤0.01% 1625
2022
Q2 		$2K Sell
205
-1,103
-84% -$9.61K ﹤0.01% 1775
2022
Q1 		$12K Sell
1,308
-85
-6% -$709 ﹤0.01% 1443
2021
Q4 		$11K Buy
+1,393
New +$12.6K ﹤0.01% 1434

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

UMB Bank's TEVA Position: Q2 2026 in Review

UMB Bank increased its Teva Pharmaceuticals (TEVA) stake by 3.2% in Q2 2026, buying an estimated $3.93K and bringing the position to 3,844 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

UMB Bank first reported a position in TEVA in Q4 2021 and has held it in 19 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • UMB Bank held 3,844 shares of Teva Pharmaceuticals worth $130K as of Q2 2026.
  • UMB Bank bought 118 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.93K.
  • Teva Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #922 holding.
  • UMB Bank first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.